Literature DB >> 16249235

Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores.

Christopher J Watson1, Catherine J Hoare, David R Garrod, Gordon L Carlson, Geoffrey Warhurst.   

Abstract

Impairment of the gut epithelial barrier by agents such as IFNgamma may play a key role in the pathogenesis of inflammatory disorders by increasing the paracellular penetration of luminal macromolecules, potentially including bacterial antigens. Owing to limitations of current paracellular probes, little is known about the precise functional changes induced by IFNgamma and how these relate to the development of increased macromolecular permeability. Here we investigate how IFNgamma modulates this pathway in T84 monolayers using a novel profiling technique that resolves different populations of paracellular pores by simultaneous analysis of 24 permeability probes of defined molecular size. Two types of functional pore present in control monolayers, an abundant restrictive pore with a radius of approximately 4.5 Angstrom and a much larger but infrequent, non-restrictive pore, were differentially regulated by IFNgamma. Incubation with IFNgamma dose-dependently and reversibly increased the frequency of the non-restrictive pores while having no significant effect on the restrictive component. Cytokine-induced increases in beta, the descriptor of the non-restrictive pore, correlated closely with increased permeability to large molecules (10 kDa) including E. coli-derived lipopolysaccharide, but not small (0.182 kDa) molecules. This effect was associated with changes in expression of the tight junction proteins occludin and claudin-1. These data suggest that IFNgamma selectively increases the transepithelial flux of large molecules by activating specific pathways within the junctional pore. One hypothesis is that this process may be activated in the early stages of the inflammatory response, facilitating the passage of large and potentially antigenic molecules across the gut without gross disruption of the barrier to small molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249235     DOI: 10.1242/jcs.02630

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  63 in total

Review 1.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

2.  Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.

Authors:  Harrison M Penrose; Ronald R Marchelletta; Moorthy Krishnan; Declan F McCole
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

3.  Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.

Authors:  Christopher R Weber; David R Raleigh; Liping Su; Le Shen; Erika A Sullivan; Yingmin Wang; Jerrold R Turner
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

4.  Biomaterial-tight junction interaction and potential impacts.

Authors:  Xiangfei Han; Ershuai Zhang; Yuanjie Shi; Boyi Song; Hong Du; Zhiqiang Cao
Journal:  J Mater Chem B       Date:  2019-07-31       Impact factor: 6.331

Review 5.  Physiology and function of the tight junction.

Authors:  James M Anderson; Christina M Van Itallie
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

6.  ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton.

Authors:  Christina M Van Itallie; Alan S Fanning; Arlene Bridges; James M Anderson
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

Review 7.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

8.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Authors:  Rose A Whelan; Sebastian Rausch; Friederike Ebner; Dorothee Günzel; Jan F Richter; Nina A Hering; Jörg-Dieter Schulzke; Anja A Kühl; Ahmed Keles; Pawel Janczyk; Karsten Nöckler; Lothar H Wieler; Susanne Hartmann
Journal:  Mol Ther       Date:  2014-07-02       Impact factor: 11.454

Review 9.  Protein kinases are potential targets to treat inflammatory bowel disease.

Authors:  Lei Yang; Yutao Yan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-11-06

10.  Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberine.

Authors:  Katherine M DiGuilio; Christina M Mercogliano; Jillian Born; Brendan Ferraro; Julie To; Brittany Mixson; Allison Smith; Mary Carmen Valenzano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.